HIV AG+AB (DETECCIÓN DE COMBINACIÓN DE ANTÍGENOS Y ANTICUERPOS DEL VIRUS DE LA INMUNODEFICIENCIA HUMANA (INMUNOENSAYO DE QUIMIOLUMINISCENCIA) - DIRUI - INVIMA Registration fbd5959bb48e33a6396ecf620482e43b
Access comprehensive regulatory information for HIV AG+AB (DETECCIÓN DE COMBINACIÓN DE ANTÍGENOS Y ANTICUERPOS DEL VIRUS DE LA INMUNODEFICIENCIA HUMANA (INMUNOENSAYO DE QUIMIOLUMINISCENCIA) - DIRUI (HIV AG+AB (DETECTION OF COMBINATION OF ANTIGENS AND ANTIBODIES OF THE HUMAN IMMUNODEFICIENCY VIRUS (CHEMILUMINESCENCE IMMUNOASSAY) - DIRUI) in the Colombia medical device market through Pure Global AI's free database. This III medical device is registered under INVIMA analysis ID fbd5959bb48e33a6396ecf620482e43b and manufactured by DIRUI INDUSTRIAL CO., LTD.
This page provides complete registration details including product type (DIAGNOSTIC REAGENT), authorised information, and regulatory compliance data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.
PARA LA DETERMINACIÓN CUALITATIVA DEL ANTÍGENO P24 DEL VIH-1 Y DEL ANTICUERPO DEL VIH-1_x000D_ Y VIH-2 (HIV AG+AB) EN SUERO O PLASMA HUMANO IN VITRO.
FOR QUALITATIVE DETERMINATION OF HIV-1 P24 ANTIGEN AND HIV-1_x000D_ ANTIBODY AND HIV-2 (HIV AG+AB) IN HUMAN SERUM OR PLASMA IN VITRO.